AI Article Synopsis

  • The study was a randomized, double-blind, placebo-controlled trial involving 48 pediatric patients with idiopathic scoliosis, focusing on the effects of subanesthetic ketamine on postoperative morphine use and recovery.
  • The objectives included determining if ketamine reduced morphine consumption, accelerated recovery, and lessened hyperalgesia and chronic pain risks compared to a placebo.
  • Results showed no significant difference in morphine consumption between the ketamine and placebo groups, indicating that the ketamine treatment did not achieve the anticipated benefits.

Article Abstract

Study Design: A randomized, double-blind, placebo-controlled study, with a six-month follow-up period.

Objectives: The aim of this study was to test the hypothesis that a 72-hour dose of subanesthetic ketamine in this surgical procedure reduces postoperative morphine use and to assess whether there are fewer adverse effects, if postoperative recovery is faster, if there is less peri-incisional hyperalgesia, or if there is lower incidence of persistent postsurgical pain.

Summary Of Background Data: Tissue injury and high opioid requirements following posterior spinal fusion surgery produce central sensitization, which can in turn be associated with hyperalgesia and chronic pain. Clinical trials involving this type of procedure using subanesthetic ketamine doses have assessed pain and morphine requirements with contradictory results. The effects of prolonged subanesthetic ketamine doses on postoperative recovery, mechanical hyperalgesia, and the incidence of chronic pain are unknown.

Methods: A total of 48 pediatric patients between 10 and 18 years diagnosed with idiopathic scoliosis were randomized to receive perioperative low-dose ketamine or placebo for 72 hours. They received general anesthesia, intraoperative remifentanil, and morphine postoperatively (patient-controlled analgesia). We measured morphine consumption, pain at rest and during movement (coughing), undesirable effects, and sedation during morphine treatment. The onset of oral intake, ambulation, and hospital stay were recorded. The extent of the peri-incisional hyperalgesia was measured at 72 hours and pain controls were conducted postsurgery.

Results: Primary endpoint results (total cumulative morphine consumption while admitted) were obtained in 44 patients. Results were 2.72 (SD 1.13) in the placebo group and 3.13 (SD 1.13) in the study group (P = 0.2903), with no significant differences. Moreover, differences were not found between the experimental group and the placebo group in the secondary endpoints analyzed.

Conclusion: Our findings do not support the routine combining of prolonged subanesthetic ketamine doses with opioids in posterior fusion surgery in children with idiopathic scoliosis.

Level Of Evidence: 2.

Download full-text PDF

Source
http://dx.doi.org/10.1097/BRS.0000000000001772DOI Listing

Publication Analysis

Top Keywords

subanesthetic ketamine
16
ketamine doses
12
perioperative low-dose
8
low-dose ketamine
8
idiopathic scoliosis
8
postoperative recovery
8
peri-incisional hyperalgesia
8
fusion surgery
8
chronic pain
8
prolonged subanesthetic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!